Hepatobiliary phase hypointensity on gadobenate dimeglumine-enhanced magnetic resonance imaging may improve the diagnosis of hepatocellular carcinoma

BACKGROUND: To determine the clinical value of hepatobiliary phase (HBP) hypointensity for noninvasive diagnosis of hepatocellular carcinoma (HCC). METHODS: A total of 246 high-risk patients with 263 selected nodules (126 HCCs, 137 non-HCCs) undergoing gadobenate dimeglumine (Gd-BOPTA)-enhanced magn...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Transl Med
Egile Nagusiak: Li, Yueming, Chen, Jianwei, Weng, Shuping, Yan, Chuan, Ye, Rongping, Zhu, Yuemin, Wen, Liting, Cao, Dairong, Hong, Jinsheng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7859813/
https://ncbi.nlm.nih.gov/pubmed/33553348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.02.38
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak